• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳房组织扩张器感染的分类:回归基础

Classification of breast tissue expander infections: Back to the basics.

作者信息

Kraenzlin Franca S, Saunders Heather, Aliu Oluseyi, Cooney Damon, Rosson Gedge D, Sacks Justin M, Broderick Kristen, Manahan Michele A

机构信息

Department of Plastic and Reconstructive Surgery, Johns Hopkins Hospital, Baltimore, Maryland.

Maryland Department of Health, Infectious Disease Epidemiology & Outbreak Response Bureau, Baltimore, Maryland.

出版信息

J Surg Oncol. 2019 Aug;120(2):142-147. doi: 10.1002/jso.25500. Epub 2019 May 18.

DOI:10.1002/jso.25500
PMID:31102461
Abstract

BACKGROUND

Infections following tissue expander (TE) placement are frequent complications in breast reconstruction. While breast surgery is a clean case, implant-based breast reconstruction has rates of infection up to 31%, decidedly higher than the typical 1% to 2% rate of surgical site infections (SSI). Few authors use the Center for Disease Control's (CDC) SSI definition for TE infections. We highlight how adoption of a consistent definition of TE infection may change how infections are researched, categorized, and ultimately managed.

METHODS

Two researchers with definitional discrepancies of infection performed an independent analysis of all postmastectomy patients receiving TEs (n = 175) in 2017.

RESULTS

Researcher One, using a clinical definition, delineated an infection rate of 19.4%. Antibiotics alone successfully treated 50% of cases. Researcher Two found an infection rate of 13.7% using CDC criteria. These infections were further delineated by a SSI rate of 6.3% and a TE infection rate post port access of 7.4%. Only 45.5% SSI's and 15.4% of TE infections were salvaged with antibiotics alone.

CONCLUSIONS

Rigorous adoption of CDC criteria for infection characterization in published research will help standardize the definition of infection and allow surgeons to create evidence-based infection prevention regimens.

摘要

背景

组织扩张器(TE)置入后的感染是乳房重建中常见的并发症。虽然乳房手术属于清洁手术,但基于植入物的乳房重建感染率高达31%,明显高于典型的手术部位感染(SSI)1%至2%的发生率。很少有作者采用疾病控制中心(CDC)的SSI定义来界定TE感染。我们强调采用一致的TE感染定义可能会改变感染的研究、分类以及最终的管理方式。

方法

两名对感染定义存在差异的研究人员对2017年所有接受TE的乳房切除术后患者(n = 175)进行了独立分析。

结果

研究人员一采用临床定义,得出感染率为19.4%。仅使用抗生素成功治疗了50%的病例。研究人员二采用CDC标准,发现感染率为13.7%。这些感染进一步细分为SSI率6.3%和端口接入后TE感染率7.4%。仅使用抗生素挽救了45.5%的SSI和15.4%的TE感染。

结论

在已发表研究中严格采用CDC标准进行感染特征描述,将有助于规范感染定义,并使外科医生能够制定基于证据的感染预防方案。

相似文献

1
Classification of breast tissue expander infections: Back to the basics.乳房组织扩张器感染的分类:回归基础
J Surg Oncol. 2019 Aug;120(2):142-147. doi: 10.1002/jso.25500. Epub 2019 May 18.
2
Identification of complications in mastectomy with immediate reconstruction using tissue expanders and permanent implants for breast cancer patients.乳腺癌患者使用组织扩张器和永久性植入物进行即刻乳房重建的乳房切除术中并发症的识别。
Breast Cancer. 2016 May;23(3):400-6. doi: 10.1007/s12282-014-0577-4. Epub 2014 Dec 30.
3
Infections after mastectomy and tissue expander placement: A multivariate regression analysis.乳房切除术和组织扩张器放置后的感染:多变量回归分析。
J Plast Reconstr Aesthet Surg. 2022 Jul;75(7):2190-2196. doi: 10.1016/j.bjps.2022.01.050. Epub 2022 Jan 31.
4
Post-Mastectomy Surgical Pocket Irrigation With Triple Antibiotic Solution vs Chlorhexidine Gluconate: A Randomized Controlled Trial Assessing Surgical Site Infections in Immediate Tissue Expander Breast Reconstruction.术后乳房切除术后手术口袋冲洗与三抗生素溶液与葡萄糖酸氯己定:评估即刻组织扩张器乳房重建中手术部位感染的随机对照试验。
Aesthet Surg J. 2021 Oct 15;41(11):NP1521-NP1528. doi: 10.1093/asj/sjab290.
5
Clinical outcome of reconstruction with tissue expanders for patients with breast cancer and mastectomy.乳腺癌乳房切除术后使用组织扩张器进行重建的临床结果。
Clin Breast Cancer. 2014 Oct;14(5):339-45. doi: 10.1016/j.clbc.2013.12.014. Epub 2014 Jan 6.
6
Preoperative β-lactam antibiotic prophylaxis is superior to bacteriostatic alternatives in immediate expander-based breast reconstruction.术前β-内酰胺类抗生素预防用药在即刻扩张器乳房重建中优于抑菌性替代药物。
J Surg Oncol. 2021 Oct;124(5):722-730. doi: 10.1002/jso.26599. Epub 2021 Jul 8.
7
Antibiotic Prophylaxis and Resistance in Surgical Site Infection After Immediate Tissue Expander Reconstruction of the Breast.乳房即刻组织扩张器重建术后手术部位感染的抗生素预防与耐药性
Ann Plast Surg. 2016 Nov;77(5):501-505. doi: 10.1097/SAP.0000000000000275.
8
Risk factors and risk scoring tool for infection during tissue expansion in tissue expander and implant breast reconstruction.组织扩张器和植入物乳房重建中组织扩张期间感染的风险因素和风险评分工具。
Breast J. 2013 Nov-Dec;19(6):618-26. doi: 10.1111/tbj.12175. Epub 2013 Sep 9.
9
Infection surveillance and prevention strategies to detect and prevent postaccess breast tissue expander infections.感染监测和预防策略,以检测和预防接入后乳房组织扩张器感染。
Infect Control Hosp Epidemiol. 2019 Nov;40(11):1275-1277. doi: 10.1017/ice.2019.222. Epub 2019 Aug 13.
10
Long-term reconstructive outcomes after expander-implant breast reconstruction with serious infectious or wound-healing complications.扩张器-植入物乳房重建术后出现严重感染或伤口愈合并发症的长期重建效果。
Ann Plast Surg. 2012 Apr;68(4):369-73. doi: 10.1097/SAP.0b013e31823aee67.

引用本文的文献

1
Chlorhexidine vs. Povidone for Skin Antisepsis in Tissue Expander-Based Breast Reconstruction: A Propensity Score-Matched Analysis.洗必泰与聚维酮用于基于组织扩张器的乳房重建术中皮肤消毒的比较:一项倾向评分匹配分析
J Clin Med. 2025 Aug 13;14(16):5734. doi: 10.3390/jcm14165734.
2
Air or Saline? A Propensity Score-Matched Analysis on the Effect of Tissue Expander Fill on Complications in Immediate Breast Reconstruction.空气还是盐水?组织扩张器填充对即刻乳房重建并发症影响的倾向评分匹配分析。
Ann Surg Oncol. 2023 Oct;30(11):6545-6553. doi: 10.1245/s10434-023-13763-2. Epub 2023 Jun 17.
3
Tissue Expander-Based Breast Reconstruction at a Major Safety-Net Hospital: Managing the Outsized Risk of Infection.
在一家大型安全网医院进行的基于组织扩张器的乳房重建:应对感染的巨大风险
Aesthet Surg J Open Forum. 2022 May 2;4:ojac036. doi: 10.1093/asjof/ojac036. eCollection 2022.
4
Microbiology of breast tissue expanders.乳房组织扩张器的微生物学
Contemp Oncol (Pozn). 2021;25(4):291-294. doi: 10.5114/wo.2021.112561. Epub 2022 Jan 5.
5
Breast Reconstruction Completion in the Obese: Does Reconstruction Technique Make a Difference in Its Achievement?肥胖患者乳房重建术的完成情况:重建技术对其实现有影响吗?
J Reconstr Microsurg. 2021 Nov;37(9):720-727. doi: 10.1055/s-0041-1726031. Epub 2021 Mar 31.
6
Clinical implications of restrictions in criteria for defining surgical site infections after mastectomy.乳房切除术后手术部位感染定义标准限制的临床意义。
Infect Control Hosp Epidemiol. 2021 Jun;42(6):767-769. doi: 10.1017/ice.2020.1288. Epub 2020 Nov 17.